
Join to View Full Profile
1275 York AveNew York, NY 10065
Phone+1 212-639-5900
Dr. Duffield is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematopathology, 2009 - 2010
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2005 - 2009
Yale School of MedicineClass of 2005
Certifications & Licensure
NY State Medical License 2020 - 2027
NJ State Medical License 2021 - 2023
MD State Medical License 2010 - 2020
PA State Medical License 2008 - 2010
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Expedited diagnosis of disseminatedinfection using targeted (amplicon-based) next-generation sequencing in an immunocompromised patient.Risa Fuller, Bruce E Petersen, Shafinaz Hussein, Christian Salib, Amy Duffield
ASM Case Reports. 2025-11-01 - An aggressive hematolymphoid neoplasm with homozygousloss shows response to EZH2 inhibition.Iman Sarami, Amy S Duffield, Suchitra Sundaram, Douglas I Lin, Christian Salib
Haematologica. 2025-11-01 - A novel 3-way translocation involving::drives AML with eosinophilia.Ariel Siegel, Joseph Tripodi, Dianna Hardatt, Brianna Kelly, Sebastian El Ghaity-Beckley
Blood Neoplasia. 2025-05-01
Abstracts/Posters
- DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid LeukemiaAmy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The High Mobility Group A1 Chromatin Regulator Is Required for Pathologic Megakaryocyte Development and Progression to Myelofibrosis in JAK2V617F Murine ModelsAmy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Gilteritinib and Venetoclax Synergize to Eliminate FLT3/ITD+ Leukemia Cells through BIMAmy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Journal of HematopathologyFebruary 20th, 2019
Researchers Link Organ Transplant Drug to Rise in Rare LymphomaFebruary 10th, 2016
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/amy-duffield
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









